Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms
- PMID: 33853885
- PMCID: PMC9488698
- DOI: 10.1183/16000617.0284-2020
Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms
Erratum in
-
"Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms." S. Malenfant, M. Lebret, É. Breton-Gagnon, et al. Eur Respir Rev 2021; 30: 200284.Eur Respir Rev. 2024 Feb 14;33(171):205284. doi: 10.1183/16000617.5284-2020. Print 2024 Jan 31. Eur Respir Rev. 2024. PMID: 38355152 Free PMC article.
Abstract
Exercise intolerance is a cardinal symptom of pulmonary arterial hypertension (PAH) and strongly impacts patients' quality of life (QoL). Although central cardiopulmonary impairments limit peak oxygen consumption (V' O2peak ) in patients with PAH, several peripheral abnormalities have been described over the recent decade as key determinants in exercise intolerance, including impaired skeletal muscle (SKM) morphology, convective O2 transport, capillarity and metabolism indicating that peripheral abnormalities play a greater role in limiting exercise capacity than previously thought. More recently, cerebrovascular alterations potentially contributing to exercise intolerance in patients with PAH were also documented. Currently, only cardiopulmonary rehabilitation has been shown to efficiently improve the peripheral components of exercise intolerance in patients with PAH. However, more extensive studies are needed to identify targeted interventions that would ultimately improve patients' exercise tolerance and QoL. The present review offers a broad and comprehensive analysis of the present literature about the complex mechanisms and their interactions limiting exercise in patients and suggests several gaps in knowledge that need to be addressed in the future for a better understanding of exercise intolerance in patients with PAH.
Copyright ©ERS 2021.
Conflict of interest statement
Conflict of interest: S. Malenfant has nothing to disclose. Conflict of interest: M. Lebret has nothing to disclose. Conflict of interest: É. Breton-Gagnon has nothing to disclose. Conflict of interest: F. Potus has nothing to disclose. Conflict of interest: R. Paulin has nothing to disclose. Conflict of interest: S. Bonnet has nothing to disclose. Conflict of interest: S. Provencher has nothing to disclose.
Figures




Similar articles
-
Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension.J Am Heart Assoc. 2023 Jun 6;12(11):e026890. doi: 10.1161/JAHA.122.026890. Epub 2023 Jun 1. J Am Heart Assoc. 2023. PMID: 37260024 Free PMC article.
-
Increasing quality of life in pulmonary arterial hypertension: is there a role for nutrition?Heart Fail Rev. 2018 Sep;23(5):711-722. doi: 10.1007/s10741-018-9717-9. Heart Fail Rev. 2018. PMID: 29909553 Free PMC article. Review.
-
Impaired angiogenesis and peripheral muscle microcirculation loss contribute to exercise intolerance in pulmonary arterial hypertension.Am J Respir Crit Care Med. 2014 Aug 1;190(3):318-28. doi: 10.1164/rccm.201402-0383OC. Am J Respir Crit Care Med. 2014. PMID: 24977625
-
Characteristics of exercise intolerance in different subgroups of pulmonary arterial hypertension associated with congenital heart disease.Int J Cardiol. 2023 Mar 15;375:29-35. doi: 10.1016/j.ijcard.2022.12.033. Epub 2022 Dec 21. Int J Cardiol. 2023. PMID: 36565957
-
Exercise training and rehabilitation in pulmonary arterial hypertension: rationale and current data evaluation.J Cardiopulm Rehabil Prev. 2013 Sep-Oct;33(5):263-73. doi: 10.1097/HCR.0b013e3182a0299a. J Cardiopulm Rehabil Prev. 2013. PMID: 23962982 Review.
Cited by
-
Skeletal muscle atrophy in pulmonary arterial hypertension: potential mechanisms and effects of physical exercise.Heart Fail Rev. 2025 Jun 21. doi: 10.1007/s10741-025-10539-6. Online ahead of print. Heart Fail Rev. 2025. PMID: 40542936 Review.
-
[Highlights 56th SEPAR Congress].Open Respir Arch. 2023 Sep 1;5(3):100265. doi: 10.1016/j.opresp.2023.100265. eCollection 2023 Jul-Sep. Open Respir Arch. 2023. PMID: 37720490 Free PMC article. Review. Spanish.
-
Skeletal Muscle Pathology in Pulmonary Arterial Hypertension and Its Contribution to Exercise Intolerance.J Am Heart Assoc. 2025 Feb 18;14(4):e036952. doi: 10.1161/JAHA.124.036952. Epub 2025 Feb 8. J Am Heart Assoc. 2025. PMID: 39921526 Free PMC article. Review.
-
Metabolic Alterations Associated With Right Ventricular Dysfunction in Pulmonary Arterial Hypertension: The Modulatory Effects and Improvement Mechanisms of Exercise.Rev Cardiovasc Med. 2025 Jul 30;26(7):37460. doi: 10.31083/RCM37460. eCollection 2025 Jul. Rev Cardiovasc Med. 2025. PMID: 40776975 Free PMC article. Review.
-
Bibliometric and visual analysis of hypoxic pulmonary hypertension from 2013 to 2022.Heliyon. 2023 Nov 4;9(11):e22044. doi: 10.1016/j.heliyon.2023.e22044. eCollection 2023 Nov. Heliyon. 2023. PMID: 38074866 Free PMC article.
References
-
- Galie N, Humbert M, Vachiery JL, et al. . 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 2015; 46: 903–975. doi:10.1183/13993003.01032-2015 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical